 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Matthew Baker,Scientia Associate Professor, UNSW Sydney (BABS), Faculty of Science.Visiting Professor, Institute of Molecular Biology and Biotechnology
Mouhand A, Nakatani K, Kono F, Hippo Y, Matsuo T, Barthe P, Peters J, Suenaga Y, Tamada T, Roumestand C, Biomol NMR Assign, 2024
Fiche JB, Schaeffer M, Houbron C, Elkhoury Youhanna C, Messina O, Barho F, Nollmann M, Methods Mol Biol, 2024
Arora N, Hazra JP, Roy S, Bhati GK, Gupta S, Yogendran KP, Chaudhuri A, Sagar A, Rakshit S, Nat Commun, 2024
Lacroix B, Vigneron S, Labbe JC, Pintard L, Lionne C, Labesse G, Castro A, Lorca T, EMBO J, 2024
Devos X, Fiche JB, Bardou M, Messina O, Houbron C, Gurgo J, Schaeffer M, Goetz M, Walter T, Mueller F, Nollmann M, Genome Biol, 2024
Team leader Gilles Labesse
Designing new drugs remains highly challenging. The group is developing an integrated approach for quicker design of drugs using structural biophysics, bioinformatics and chemistry. The corresponding techniques are implemented in a new platform for structure-based screening.
Christian Roumestand and Nathalie Declerck
Pau Bernadó and Nathalie Sibille
Patrick Bron
Gilles Labesse
William Bourguet and Albane Le Maire
Alessandro Barducci
Marcelo Nollmann
Manouk Abkarian and Francesco Pedaci
Pierre-Emmanuel Milhiet and Emmanuel Margeat
Jérôme Bonnet and Martin Cohen-Gonsaud
Alessandro Barducci
Thomas Robert
Guillaume Cambray
Jakub Gruszczyk
